recording

POSTERS ESMO 2024

esmo

Tumores neuroendocrinos

Jorge Hernando Cubero

acceso

Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry.

  • Jorge Hernando Cubero

    Hospital Universitario Vall d’Hebron. Barcelona

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON